{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:09:33Z","timestamp":1776650973654,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T00:00:00Z","timestamp":1288483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00210-010-0573-y","type":"journal-article","created":{"date-parts":[[2010,11,6]],"date-time":"2010-11-06T19:21:08Z","timestamp":1289071268000},"page":"35-44","source":"Crossref","is-referenced-by-count":30,"title":["Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension"],"prefix":"10.1007","volume":"383","author":[{"given":"Diogo M. O.","family":"Mar\u00e7al","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elen","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisson","family":"Martins-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla S.","family":"Ceron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel F.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose E.","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"issue":"17","key":"573_CR1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","volume":"113","author":"SH Ahmed","year":"2006","unstructured":"Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR (2006) Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113(17):2089\u20132096","journal-title":"Circulation"},{"issue":"3","key":"573_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.pharmthera.2005.12.003","volume":"111","author":"SM Arribas","year":"2006","unstructured":"Arribas SM, Hinek A, Gonzalez MC (2006) Elastic fibres and vascular structure in hypertension. Pharmacol Ther 111(3):771\u2013791","journal-title":"Pharmacol Ther"},{"issue":"5","key":"573_CR3","doi-asserted-by":"crossref","first-page":"H1778","DOI":"10.1152\/ajpheart.00494.2002","volume":"284","author":"K Asanuma","year":"2003","unstructured":"Asanuma K, Magid R, Johnson C, Nerem RM, Galis ZS, O\u2019Callaghan CJ, Williams B (2003) Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 284(5):H1778\u2013H1784","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"573_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.HYP.0000154680.44184.01","volume":"45","author":"C Bouvet","year":"2005","unstructured":"Bouvet C, Gilbert LA, Girardot D, deBlois D, Moreau P (2005) Different involvement of extracellular matrix components in small and large arteries during chronic no synthase inhibition. Hypertension 45(3):432\u2013437","journal-title":"Hypertension"},{"key":"573_CR5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.RES.0000181759.63239.21","volume":"97","author":"Y Castier","year":"2005","unstructured":"Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S (2005) P47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97:533\u2013540","journal-title":"Circ Res"},{"issue":"1\u20133","key":"573_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.07.051","volume":"498","author":"MM Castro","year":"2004","unstructured":"Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE (2004) Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol 498(1\u20133):189\u2013194","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"573_CR7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","volume":"198","author":"MM Castro","year":"2008","unstructured":"Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE (2008) Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 198(2):320\u2013331","journal-title":"Atherosclerosis"},{"issue":"9","key":"573_CR8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","volume":"46","author":"MM Castro","year":"2009","unstructured":"Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE (2009) Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic Biol Med 46(9):1298\u20131307","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"573_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2009.11.005","volume":"29","author":"MM Castro","year":"2010","unstructured":"Castro MM, Rizzi E, Prado CM, Rossi MA, Tanus-Santos JE, Gerlach RF (2010) Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling. Matrix Biol 29(3):194\u2013201","journal-title":"Matrix Biol"},{"issue":"1","key":"573_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","volume":"160","author":"CS Ceron","year":"2010","unstructured":"Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC, Gerlach RF, Tanus-Santos JE (2010) Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br J Pharmacol 160(1):77\u201387","journal-title":"Br J Pharmacol"},{"issue":"5 Pt 2","key":"573_CR11","first-page":"H2002","volume":"277","author":"NC Chesler","year":"1999","unstructured":"Chesler NC, Ku DN, Galis ZS (1999) Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol 277(5 Pt 2):H2002\u2013H2009","journal-title":"Am J Physiol"},{"issue":"1","key":"573_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2005.09.002","volume":"111","author":"G Cohuet","year":"2006","unstructured":"Cohuet G, Struijker-Boudier H (2006) Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther 111(1):81\u201398","journal-title":"Pharmacol Ther"},{"issue":"4","key":"573_CR13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-7843.2008.00299.x","volume":"103","author":"CA Dias-Junior","year":"2008","unstructured":"Dias-Junior CA, Montenegro MF, Florencio BC, Tanus-Santos JE (2008) Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic Clin Pharmacol Toxicol 103(4):374\u2013379","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"573_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.107.089631","volume":"50","author":"M Flamant","year":"2007","unstructured":"Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S (2007) Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 50(1):212\u2013218","journal-title":"Hypertension"},{"issue":"3","key":"573_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","volume":"90","author":"ZS Galis","year":"2002","unstructured":"Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90(3):251\u2013262","journal-title":"Circ Res"},{"issue":"1464","key":"573_CR16","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1098\/rstb.2005.1774","volume":"360","author":"T Godfraind","year":"2005","unstructured":"Godfraind T (2005) Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Philos Trans R Soc Lond B Biol Sci 360(1464):2259\u20132272","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"17","key":"573_CR17","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/01.CIR.0000093661.90582.c4","volume":"108","author":"KK Griendling","year":"2003","unstructured":"Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108(17):2034\u20132040","journal-title":"Circulation"},{"issue":"11","key":"573_CR18","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1161\/01.RES.0000077044.60138.7C","volume":"92","author":"K Grote","year":"2003","unstructured":"Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, Schieffer B (2003) Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92(11):e80\u2013e86","journal-title":"Circ Res"},{"issue":"8","key":"573_CR19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.CIR.0000115521.95662.7A","volume":"109","author":"S Lehoux","year":"2004","unstructured":"Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A (2004) Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 109(8):1041\u20131047","journal-title":"Circulation"},{"key":"573_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2004.12.152","volume":"328","author":"M Luchtefeld","year":"2005","unstructured":"Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Struber M, Haverich A, Bavendiek U, Drexler H, Schieffer B (2005) Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 328:183\u2013188","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"573_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.fjc.0000196241.96759.71","volume":"47","author":"ML Martinez","year":"2006","unstructured":"Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF, Tanus-Santos JE (2006) Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol 47(1):117\u2013122","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1\u20133","key":"573_CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2008.06.096","volume":"591","author":"ML Martinez","year":"2008","unstructured":"Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE (2008a) Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. Eur J Pharmacol 591(1\u20133):224\u2013230","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"573_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2008.10.007","volume":"599","author":"ML Martinez","year":"2008","unstructured":"Martinez ML, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE (2008b) Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. Eur J Pharmacol 599(1\u20133):110\u2013116","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"573_CR24","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/01.ATV.0000097770.66965.2A","volume":"23","author":"RP Mason","year":"2003","unstructured":"Mason RP, Marche P, Hintze TH (2003) Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 23(12):2155\u20132163","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1994.tb24723.x","volume":"732","author":"LM Matrisian","year":"1994","unstructured":"Matrisian LM (1994) Matrix metalloproteinase gene expression. Ann NY Acad Sci 732:42\u201350","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"573_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00210-010-0546-1","volume":"382","author":"MF Montenegro","year":"2010","unstructured":"Montenegro MF, Neto-Neves EM, Dias-Junior CA, Ceron CS, Castro MM, Gomes VA, Kanashiro A, Tanus-Santos JE (2010) Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension. Naunyn Schmiedebergs Arch Pharmacol 382(4):293\u2013301","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"573_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.1994.tb24722.x","volume":"732","author":"G Murphy","year":"1994","unstructured":"Murphy G, Willenbrock F, Crabbe T, O\u2019Shea M, Ward R, Atkinson S, O\u2019Connell J, Docherty A (1994) Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 732:31\u201341","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"573_CR28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.freeradbiomed.2004.06.008","volume":"37","author":"KK Nelson","year":"2004","unstructured":"Nelson KK, Melendez JA (2004) Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37(6):768\u2013784","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"573_CR29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardiores.2005.08.002","volume":"69","author":"AC Newby","year":"2006","unstructured":"Newby AC (2006) Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69(3):614\u2013624","journal-title":"Cardiovasc Res"},{"issue":"31","key":"573_CR30","doi-asserted-by":"crossref","first-page":"29596","DOI":"10.1074\/jbc.M102417200","volume":"276","author":"T Okamoto","year":"2001","unstructured":"Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276(31):29596\u201329602","journal-title":"J Biol Chem"},{"issue":"8","key":"573_CR31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.matbio.2007.07.001","volume":"26","author":"HJ Ra","year":"2007","unstructured":"Ra HJ, Parks WC (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol 26(8):587\u2013596","journal-title":"Matrix Biol"},{"issue":"2","key":"573_CR32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","volume":"75","author":"JD Raffetto","year":"2008","unstructured":"Raffetto JD, Khalil RA (2008) Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75(2):346\u2013359","journal-title":"Biochem Pharmacol"},{"key":"573_CR33","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI119076","volume":"98","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98:2572\u20132579","journal-title":"J Clin Invest"},{"issue":"1","key":"573_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2005.04140.x","volume":"8","author":"DA Sica","year":"2006","unstructured":"Sica DA (2006) Pharmacotherapy review: calcium channel blockers. J Clin Hypertens (Greenwich) 8(1):53\u201356","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"573_CR35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cardiores.2005.11.026","volume":"69","author":"JP Sluijter","year":"2006","unstructured":"Sluijter JP, de Kleijn DP, Pasterkamp G (2006) Vascular remodeling and protease inhibition\u2014bench to bedside. Cardiovasc Res 69(3):595\u2013603","journal-title":"Cardiovasc Res"},{"issue":"8","key":"573_CR36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00004872-200108000-00005","volume":"19","author":"S Taddei","year":"2001","unstructured":"Taddei S, Virdis A, Ghiadoni L, Magagna A, Pasini AF, Garbin U, Cominacini L, Salvetti A (2001) Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens 19(8):1379\u20131386","journal-title":"J Hypertens"},{"issue":"4","key":"573_CR37","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00005344-200304000-00006","volume":"41","author":"D Tomassoni","year":"2003","unstructured":"Tomassoni D, Sabbatini M, Amenta F (2003) Effect of different dihydropyridine-type Ca2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats. J Cardiovasc Pharmacol 41(4):544\u2013552","journal-title":"J Cardiovasc Pharmacol"},{"key":"573_CR38","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","volume":"87","author":"HE Wart Van","year":"1990","unstructured":"Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578\u20135582","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"573_CR39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bcp.2008.11.004","volume":"77","author":"S Viappiani","year":"2009","unstructured":"Viappiani S, Nicolescu AC, Holt A, Sawicki G, Crawford BD, Leon H, van Mulligen T, Schulz R (2009) Activation and modulation of 72\u00a0kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol 77(5):826\u2013834","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"573_CR40","doi-asserted-by":"crossref","first-page":"H2438","DOI":"10.1152\/ajpheart.00900.2006","volume":"292","author":"SW Watts","year":"2007","unstructured":"Watts SW, Rondelli C, Thakali K, Li X, Uhal B, Pervaiz MH, Watson RE, Fink GD (2007) Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 292(5):H2438\u2013H2448","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"573_CR41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.0000151373.33830.41","volume":"25","author":"McEniery CM Yasmin","year":"2005","unstructured":"Yasmin McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB (2005) Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25(2):372","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"573_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00005344-200408000-00012","volume":"44","author":"H Yue","year":"2004","unstructured":"Yue H, Uzui H, Shimizu H, Nakano A, Mitsuke Y, Ueda T, Lee JD (2004) Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts. J Cardiovasc Pharmacol 44(2):223\u2013230","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-010-0573-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0573-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:02:27Z","timestamp":1558641747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-010-0573-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1007\/s00210-010-0573-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]}}}